EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Nanoparticle-Driven Modulation of Mucosal Immunity and Interplay with the Microbiome

Won Jung, Young Min Son

Journal of Microbiology and Biotechnology · 2025

DOI: 10.4014/jmb.2504.04033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Microbiology and Biotechnology, 2025. Verfasst von Won Jung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biotechnology, Chung-Ang University, Anseong-si 17546, Republic of Korea. Hauptthemen laut MEDLINE: Immunity, Mucosal, Nanoparticles, Microbiota. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Chung-Ang University, Korea Health Industry Development Institute, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucosal surfaces are dynamic immunological interfaces that play a critical role in maintaining host defense and microbial homeostasis. Disruptions in the interaction between the mucosal immune system and its commensal microbiota have been associated with the onset of several diseases, including inflammatory bowel disease, asthma, and bacterial vaginosis. This review examines recent advances in nanoparticle (NP)-based strategies aimed at modulating mucosal immunity and restructuring microbial communities. It highlights how organic and inorganic NPs such as polysaccharide-based carriers, lipid NPs, and metallic nanomaterials enhance the delivery and stability of probiotics, prebiotics, and synbiotics, and facilitate targeted immunomodulation across gastrointestinal, respiratory, and female reproductive mucosal tissues. NP-based strategies are particularly emphasized for their ability to penetrate mucus barriers, facilitate microbial colonization, modulate cytokine activity, and enhance the restoration of epithelial barrier function. Disease-specific applications, including NP-based therapies for colitis, respiratory inflammation, and vaginal dysbiosis, are also discussed. In addition, this review outlines current challenges related to biosafety, targeting specificity, and clinical translation, and suggests future directions for research. Altogether, NP platforms offer a promising avenue for the precise modulation of mucosal immunity and microbiota, with significant potential in the prevention and treatment of mucosal-associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, MucosalNanoparticlesMicrobiotaHumansAnimalsProbioticsFemaleMucous MembranePrebioticsDysbiosis

Stichwörter der Autor:innen

Mucosal immunitymicrobiome modulationnanoparticle-based deliveryprebiotic nanoparticleprobiotic nanoparticlesynbiotic nanoparticle

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Department of Systems Biotechnology, Chung-Ang University, Anseong-si 17546, Republic of Korea.

Förderung

  • Chung-Ang University
  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare
  • National Research Foundation of Korea
  • Ministry of Science and ICT

Zitieren

APA

Jung, W., & Son, Y. M. (2025). Nanoparticle-Driven Modulation of Mucosal Immunity and Interplay with the Microbiome. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2504.04033

Vancouver

Jung W, Son YM. Nanoparticle-Driven Modulation of Mucosal Immunity and Interplay with the Microbiome. Journal of Microbiology and Biotechnology. 2025. doi:10.4014/jmb.2504.04033

BibTeX
@article{Jung2025,
  author = {Jung, Won and Son, Young Min},
  title = {Nanoparticle-Driven Modulation of Mucosal Immunity and Interplay with the Microbiome},
  journal = {Journal of Microbiology and Biotechnology},
  year = {2025},
  doi = {10.4014/jmb.2504.04033}
}
Kostenlos starten →